Song Liu

Dr. Song Liu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2023 in Medicine
Verified
Journal Article
Open access
XHXiaoqing Mm Hao
Xiaoqing Mm Hao
XZXiaodi Mb Zhu
Xiaodi Mb Zhu
HTHuiqun Tian
Huiqun Tian
GLGuanxi Mb Lai
Guanxi Mb Lai
WZWei Zhang
Wei Zhang
SLSong Liu
Song Liu
Research has demonstrated that obesity is an important risk factor for cancer progression. Orlistat is a lipase inhibitor with promising therapeutic effects on obesity. In addition to being regarded as a slimming drug, a growing number of studies in recent years have suggested that orlistat has anti-tumor activities, while the underlying mechanism is still not well elucidated. This paper reviewed recent pharmacological effects and mechanisms of orlistat against tumors and found that orlistat can target cancer cells through activation or suppression of multiple signaling pathways. It can induce tumor cells apoptosis or death, interfere with tumor cells’ cycles controlling, suppress fatty acid synthase activity, increase ferroptosis, inhibit tumor angiogenesis, and improve tumor cells glycolytic. Thus, this review may shed new light on anti-tumor mechanism and drug repurposing of orlistat, and anti-tumor drug development.

9 September 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
SLSong Liu
Song Liu
SYShaochun Yuan
Shaochun Yuan
XGXiaoman Gao
Xiaoman Gao
XTXin Tao
Xin Tao
WYWenjuan Yu
Wenjuan Yu
AXAnlong Xu
Anlong Xu
The discovery of ancestral RAG transposons in early deuterostomia reveals the origin of vertebrate V(D)J recombination. Here, we analyze the functional regulation of a RAG transposon, ProtoRAG, in lancelet. We find that a specific interaction between the cis-acting element within the TIR sequences of ProtoRAG and a trans-acting factor, lancelet YY1-like (bbYY1), is important for the transcriptional regulation of lancelet RAG-like genes (bbRAG1L and bbRAG2L). Mechanistically, bbYY1 suppresses the transposition of ProtoRAG; meanwhile, bbYY1 promotes host DNA rejoins (HDJ) and TIR-TIR joints (TTJ) after TIR-dependent excision by facilitating the binding of bbRAG1L/2 L to TIR-containing DNA, and by interacting with the bbRAG1L/2 L complex. Our data thus suggest that bbYY1 has dual functions in fine-tuning the activity of ProtoRAG and maintaining the genome stability of the host.

1 December 2023 in Human Gene Therapy
Verified
Journal Article
Closed access
JLJiawen Li
Jiawen Li
CTChuxi Tang
Chuxi Tang
GLGuozheng Liang
Guozheng Liang
HTHuiqun Tian
Huiqun Tian
GLGuanxi Lai
Guanxi Lai
HSHongwei Shao
Hongwei Shao
The clustered regularly interspaced short palindromic repeat (CRISPR)- CRISPR-associated (Cas) system is a powerful genomic DNA editing tool. The increased applications of gene editing tools, including the CRISPR-Cas system, have contributed to recent advances in biological fields, such as genetic disease therapy, disease-associated gene screening and detection, and cancer therapy. However, the major limiting factor for the wide application of gene editing tools is gene editing efficiency. This review summarizes the recent advances in factors affecting the gene editing efficiency of the CRISPR-Cas9 system and the CRISPR-Cas9 system optimization strategies. The homology-directed repair efficiency-related signal pathways and the form and delivery method of the CRISPR-Cas9 system are the major factors that influence the repair efficiency of gene editing tools. Based on these influencing factors, several strategies have been developed to improve the repair efficiency of gene editing tools. This review provided novel insights for improving the repair efficiency of the CRISPR-Cas9 gene editing system, which may enable the development and improvement of gene editing tools.

20 May 2026 in Brain Research Bulletin
Verified
Journal Article
Open access
SWShijin Wu
Shijin Wu
XGXiaofa Gao
Xiaofa Gao
YZYuyang Zhou
Yuyang Zhou
ZLZibo Lin
Zibo Lin
CCChuting Chen
Chuting Chen
SLSong Liu
Song Liu
Depression is a prevalent and debilitating mental disorder, imposing a leading global public health burden. First-line monoamine-based antidepressants are ineffective in a substantial proportion of patients, many of whom develop treatment-resistant depression (TRD). Emerging evidence strongly implicates inflammation in the pathophysiology of TRD, with a heightened inflammatory profile observed in patients who respond poorly to conventional therapies. Consequently, targeting inflammatory pathways represents a promising novel therapeutic strategy for TRD. This review examines the interplay between inflammation and TRD, elucidates the mechanisms by which inflammation contributes to depression, and evaluates current anti-inflammatory interventions and their regulatory mechanisms. A particular focus is placed on the pivotal role of tumor necrosis factor-alpha (TNF-α) in the pathogenesis of TRD and the potential of anti-TNF-α monoclonal antibodies as a targeted treatment. We propose that TNF-α serves not only as a promising therapeutic target but also as a valuable biomarker for TRD treatment. These perspectives may pave the way for precision medicine in TRD and inspire novel therapeutic approaches for depression.

19 November 2025 in International Journal of Pharmacology
Verified
Journal Article
Open access
QWQian Wu
Qian Wu
JZJia Zeng
Jia Zeng
YWYixiang Wu
Yixiang Wu
GLGuanxi Lai
Guanxi Lai
XZXiaoshan Zheng
Xiaoshan Zheng
SLSong Liu
Song Liu
Background: This study aimed to investigate the main active ingredients and potential mechanism of action of Euonymus alatus (Thunb.) Siebold (EA), a traditional Chinese medicine that is used to alleviate symptoms of rheumatoid arthritis (RA). Methods: Potential targets of EA and related pathways in the treatment of RA were identified using the Traditional Chinese Medicine Systems Pharmacology (TCMSP) database and analysis tools, SymMap, GeneCards, Swiss Target Prediction database, Metascape, and molecular docking. The anti-inflammatory effect of the predicted core active ingredient in EA was validated using lipopolysaccharide (LPS)-induced RAW 264.7 macrophages in vitro. Results: The main active ingredients in EA that are influential in the treatment of RA are likely to be flavonoids and polyphenols, such as kaempferol, quercetin, baicalein, wogonin, and oroxylin A. These active ingredients may target AKT1, BCL2, IGF1R, SRC, PTGS2, and EGFR to affect the NF-κB, mTOR, and related signaling pathways, as determined by Kyoto Encyclopedia of Genes and Genomes (KEGG) and Gene Ontology (GO) analyses. Meanwhile, the molecular docking results suggested that these active ingredients most likely target AKT1, BCL-2, and PTGS-2. Experimental studies have shown that the EA active ingredient, baicalein, can suppress macrophage proliferation, TNF-α expression, and reactive oxygen species (ROS) production. Conclusion: The active ingredients in EA may target AKT, BCL-2, and PTGS-2 to mediate the regulation of the PI3K/AKT signaling pathway in RA treatment.

15 June 2025
Verified
Book Chapter
Closed access
PDF file
SLSong Liu
Song Liu
BLBing Liu
Bing Liu
CZChunfu Zheng
Chunfu Zheng